Human Papillomavirus (HPV) Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight

Human Papillomavirus (HPV) Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight

““Human Papillomavirus (HPV) Market Insights, Epidemiology, and Market Forecast-2030””

Delveinsight has launched a new report on “Human Papillomavirus (HPV) Market Insights, Epidemiology, and Market Forecast-2030


DelveInsight’s “Human Papillomavirus (HPV) Market Insights, Epidemiology, and Market Forecast-2030 report delivers an in-depth understanding of the Human Papillomavirus (HPV), historical and forecasted epidemiology as well as the Human Papillomavirus (HPV) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Some Key HPV Market Facts:

  • The global HPV associated disorders market size was estimated at USD 16.34 billion in 2018.
  • According to DelveInsight, every day in the US, about 12,000 people of ages 15-24 are infected with HPV.
  • About 79 million Americans are currently infected with HPV and about 14 million people is likely to become newly infected each.
  • According to DelveInsight, every year, approximately 19,400 women and 12,100 men are affected by HPV causing cancers.


Scope of Report:

  • The report covers the descriptive overview of Human Papillomavirus (HPV), explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Human Papillomavirus (HPV) epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Human Papillomavirus (HPV) are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Human Papillomavirus (HPV) market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Human Papillomavirus (HPV) market



Request for Free Sample Report:


Human Papillomavirus (HPV) is the most common DNA virus that causes infection in the epithelial cells of skin and mucosa in which moist epithelial surfaces (squamous cells) include all areas covered by skin and/or mucosa such as the mouth interior, throat, tongue, tonsils, vagina, cervix, vulva, penis (the urethra – the opening), and anus.

Contact of the above-mentioned areas with a virus leads to the transmission of the virus into, allowing it to transfer between epithelial cells. After establishment, sexual contacts, both conventional and oral becomes the means of transferring HPV through direct skin to skin contact. Other possible pathways for the transfer of virus is poorly known.

HPV can cause cervical and other cancers including cancer of the vulva, vagina, penis, or anus. It can also cause cancer in the back of the throat, including the base of the tongue and tonsils (called oropharyngeal cancer). Cancer often takes years, even decades, to develop after a person gets HPV. The types of HPV that can cause genital warts are not the same as the types of HPV that can cause cancers.


Request for Free Sample Report:


The percentages of cancers caused by oncogenic HPV are as follows:

  • Anal cancer – 90%
  • Vulvar cancer – 40%
  • Vaginal cancer – 40%
  • Oropharyngeal cancer – 12%
  • Oral cancer – 3%


Request for Free Sample Report:


Some of the Key Companies:

  • Merck & Co.  
  • GlaxoSmithKline
  • F. Hoffmann-La Roche
  • Pfizer
  • Allergan
  • AstraZeneca
  • Biocon Ltd.
  • Eli Lilly and Company
  • And Many Others


Some of Drugs Covered:

  • Gardasil
  • Ervarix
  • And Many Others


Request for Free Sample Report:


Table of Contents:

1. Key Insights

2. Executive Summary of Human Papillomavirus (HPV)

3. Competitive Intelligence Analysis for Human Papillomavirus (HPV)

4. Human Papillomavirus (HPV): Market Overview at a Glance

5. Human Papillomavirus (HPV): Disease Background and Overview

6. Patient Journey

7. Human Papillomavirus (HPV) Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Human Papillomavirus (HPV) Treatment

11. Marketed Products

12. Emerging Therapies

13. Human Papillomavirus (HPV): Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Human Papillomavirus (HPV)

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer


Request for Detailed TOC:


About DelveInsight:

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States